Investor Relations


2019 BIO International Convention - ActoBio Therapeutics
Monday, June 3, 2019
2:15pm - 2:30pm EDT

Pieter Rottiers, PhD, Chief Executive Officer of ActoBio Therapeutics, a wholly-owned subsidiary of Intrexon and innovative clinical-stage biotechnology company developing a new class of microbe-based therapeutic agents, will be giving a company presentation on Monday June 3rd from 2:15-2:30 pm ET. The presentation will not be webcast.